These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

880 related articles for article (PubMed ID: 16144208)

  • 1. Cirrhosis--can we reverse hepatic fibrosis?
    Tangkijvanich P; Yee HF
    Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis.
    Liu X; Hu H; Yin JQ
    Liver Int; 2006 Feb; 26(1):8-22. PubMed ID: 16420505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutical targets for revert liver fibrosis].
    García B L; Gálvez G J; Armendáriz B J
    Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
    Friedman SL
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):98-105. PubMed ID: 16265071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene regulation in hepatic stellate cell.
    Lang A; Brenner DA
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):173-9. PubMed ID: 10363203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic stellate cells as a target for the treatment of liver fibrosis.
    Bataller R; Brenner DA
    Semin Liver Dis; 2001 Aug; 21(3):437-51. PubMed ID: 11586471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
    Gressner AM
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
    Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
    Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic stellate cells and the reversal of fibrosis.
    Kisseleva T; Brenner DA
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
    Svegliati-Baroni G; De Minicis S; Marzioni M
    Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatic fibrogenesis].
    Loréal O; Clément B; Deugnier Y
    Rev Prat; 1997 Mar; 47(5):482-6. PubMed ID: 9138408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic liver injury, TGF-beta, and cancer.
    Bissell DM
    Exp Mol Med; 2001 Dec; 33(4):179-90. PubMed ID: 11795478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
    Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.
    Kuriyama S; Yokoyama F; Inoue H; Takano J; Ogawa M; Kita Y; Yoshiji H; Deguchi A; Kimura Y; Himoto T; Yoneyama H; Kurokohchi K; Masaki T; Uchida N; Watanabe S
    Int J Mol Med; 2007 Feb; 19(2):317-24. PubMed ID: 17203207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
    Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
    Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
    Wasmuth HE; Lammert F; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.